ProCE: The Pharmacy Practice Podcast – Details, episodes & analysis

In this episode, learn how early and sustained HBV care can be enhanced by expanding the role of primary care providers in HBV management. Learn how to:

• Engage key stakeholders in the provision of HBV care​
• Provide HBV management resources to support PCPs who are doing screening​
• Consider specialty and primary care collaborations that empower PCPs with clear guidance on how to manage patients living with HBV

Presenters:

Su Wang, MD, MPH, FACP
Medical Director
Center for Asian Health and Viral Hepatitis Programs
Cooperman Barnabas Medical Center
RWJBarnabas-Rutgers Medical Group
Associate Member
Health Care Policy and Aging Research
The Rutgers Institute for Health
Senior Advisor
Global Health, Hepatitis B Foundation
Florham Park, New Jersey

Richard R. Andrews, MD, MPH
President, Houston Viral Hepatitis Task Force
Former Co-Chair, National Task Force on Hepatitis B
Board-Certified Family Medicine
Addiction Medicine Physician
Houston, Texas

Ruth Brogden, MPH
Patient Advocate

Amy S. Tang, MD
Former Co-Chair, National Task Force on Hepatitis B
Director of Immigrant Health
North East Medical Services
San Francisco, California

Link to full program: 
https://bit.ly/3TuqFHI

Link to the slides:
https://bit.ly/44hXpHu

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

In this episode, Mark S. Sulkowski, MD, FIDSA, FAASLD; Tatyana Kushner, MD, MSCE; Paul Y. Kwo, MD; and patient advocate Jacki Chen, PhD, consider barriers and solutions for more expansive HBV treatment in the United States. Topics include:

• Patient subgroups to consider for treatment outside guideline criteria
• Adverse event and cost-effectiveness considerations
• Integration of patient perspectives in wider treatment

Presenters:

Mark S. Sulkowski, MD, FIDSA, FAASLD
Professor of Medicine
Director, Division of Infectious Diseases, Johns Hopkins Bayview Medical Center
Johns Hopkins University School of Medicine
Baltimore, Maryland

Tatyana Kushner, MD, MSCE
Associate Professor
Division of Liver Diseases
Icahn School of Medicine at Mount Sinai
New York, New York

Paul Y. Kwo, MD
Professor of Medicine
Director of Hepatology
Stanford University School of Medicine
Palo Alto, California

Jacki Chen, PhD
Patient Advocate 

Link to full program: 
https://bit.ly/3TuqFHI

Link to the slides:
https://bit.ly/4a60GM4

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

In this episode, Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP, and Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP, discuss the use of mineralocorticoid receptor antagonists in patients with chronic kidney disease and type 2 diabetes, including:

• Overview of chronic kidney disease
• Guideline recommendations
• Evidence for finerenone
• Role of the pharmacist

Presenter:

Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP
Endocrine Clinical Pharmacy Specialist
CGM and Remote Monitoring Program Coordinator
Endocrinology and Metabolism Institute
Cleveland Clinic
Cleveland, Ohio

Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP
Vice Chair and Allen I. White Distinguished Professor
Department of Pharmacotherapy
College of Pharmacy and Pharmaceutical Sciences  
Washington State University
Spokane, Washington

Review the downloadable slideset and the full program at:
https://bit.ly/3wxNAod

This podcast is the third in a series of three featuring insights from expert cardiology pharmacists on nonvalvular atrial fibrillation (NVAF). In this episode, pharmacist Kathleen A. Lusk, PharmD, BCPS, BCCP, provides an overview of health disparities, patient engagement, and collaborative team-based care to optimize outcomes for patients with NVAF. Dr Lusk reviews best practices in using the principles of motivational interviewing to employ shared decision-making and models these strategies with 2 simulated clinical patient visits. Common barriers, such as medication access and adherence, also are discussed, along with practical solutions for overcoming these care obstacles. 

Presenter:

Kathleen A. Lusk, PharmD, BCPS, BCCP
Associate Professor and Vice Chair
Department of Pharmacy Practice
University of the Incarnate Word Feik School of Pharmacy 
Adjunct Assistant Professor
Clinical Pharmacy Specialist
Division of Cardiology
Department of Medicine
UT Health San Antonio
San Antonio, Texas

Content is based on an online CE program supported by an educational grant from the Bristol Myers Squibb Pfizer Alliance.

This podcast series was first delivered as live webinars, which are now available as on-demand, CE-certified microlearning modules with downloadable slidesets. The program also features a ClinicalThought commentary and a downloadable infographic reference guide. To access the full program, go to:
https://bit.ly/3OMazV8

This podcast is the second in a series of three featuring insights from expert cardiology pharmacists on nonvalvular atrial fibrillation (NVAF). In this episode, cardiology pharmacist Stephanie Dwyer Kaluzna, PharmD, BCCP, reviews key literature and guideline recommendations for stroke prevention in patients with NVAF. Dr Dwyer Kaluzna discusses the most recent evidence for prescribing, dosing, and monitoring direct oral anticoagulants (DOACs); using the risk-screening tools HAS-BLED and CHA2DS2-VASc to design patient-specific pharmacotherapy plans; and the use of DOACs in special patient populations, including older patients, patients with end-stage renal disease, and patients with low or high body weights.

Presenter:

Stephanie Dwyer Kaluzna, PharmD, BCCP  
Clinical Assistant Professor
Department of Pharmacy Practice
University of Illinois Chicago College of Pharmacy
Cardiovascular Clinical Pharmacist
University of Illinois Hospital and Health Science System
Chicago, Illinois

Content is based on an online CE program supported by an educational grant from the Bristol Myers Squibb Pfizer Alliance.

This podcast series was first delivered as live webinars, which are now available as on-demand, CE-certified microlearning modules with downloadable slidesets. The program also features a ClinicalThought commentary and a downloadable infographic reference guide. To access the full program, go to
https://bit.ly/3OMazV8

This podcast is the first in a series of three featuring cardiology pharmacists Kathleen A. Lusk, PharmD, BCPS, BCCP, and Stephanie Dwyer Kaluzna, PharmD, BCCP. In this episode, Drs Lusk and Dwyer Kaluzna provide an overview of nonvalvular atrial fibrillation (NVAF), including prevalence, burden, and consequences of undiagnosed NVAF and the role of pharmacists in screening for the condition in various pharmacy settings.

Presenters:

Kathleen A. Lusk, PharmD, BCPS, BCCP  
Associate Professor and Vice Chair  
Department of Pharmacy Practice
University of the Incarnate Word Feik School of Pharmacy  
Adjunct Assistant Professor
Clinical Pharmacy Specialist
Division of Cardiology
Department of Medicine
UT Health San Antonio
San Antonio, Texas

Stephanie Dwyer Kaluzna, PharmD, BCCP  
Clinical Assistant Professor
Department of Pharmacy Practice
University of Illinois Chicago College of Pharmacy
Cardiovascular Clinical Pharmacist
University of Illinois Hospital and Health Science System
Chicago, Illinois

Content is based on an online CE program supported by an educational grant from the Bristol Myers Squibb Pfizer Alliance.

This podcast series was first delivered as live webinars, which are now available as on-demand, CE-certified microlearning modules with downloadable slidesets. The program also features a ClinicalThought commentary and a downloadable infographic reference guide. To access the full program, go to
https://bit.ly/3OMazV8

In this episode, pharmacists Megan Adelman, PharmD, BCPS, BCGP, CDCES, and Elizabeth Pogge, PharmD, MPH, BCPS-AQ Cardiology, BCGP, FASCP, FAzPA, provide an overview of obesity, including pathophysiology and the benefits of long-term weight loss, and discuss guideline recommendations for treatment, pharmacotherapy options including injectable agents, and overcoming barriers to care.

Presenters:

Megan Adelman, PharmD, BCPS, BCGP, CDCES
Family Medicine Clinical Specialist
Center for Family Medicine
Cleveland Clinic Akron General
Akron, Ohio

Elizabeth Pogge, PharmD, MPH, BCPS-AQ Cardiology, BCGP, FASCP, FAzPA
Professor
Department of Pharmacy Practice
College of Pharmacy-Glendale
Midwestern University
Glendale, Arizona

Content based on an online CE program supported by an educational grant from Novo Nordisk, Inc.

Link to full program:
https://bit.ly/3EAARVu

Faculty

Tyree H. Kiser, PharmD, FCCM, FCCP, BCCCP, BCPS
Professor, Department of Clinical Pharmacy
University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
Critical Care Pharmacy Specialist, Department of Pharmacy
University of Colorado Hospital
Aurora, Colorado

Charles E. “Kurt” Mahan, PharmD, PhC, FASHP, FCCP
Adjunct Associate Professor, Pharmacy
University of New Mexico Health Sciences Center
Albuquerque, New Mexico
  

Content based on a CE activity supported by an educational grant from Alexion, AstraZeneca Rare Disease.
  

Link to full activity: https://www.proce.com/Anticoagulation

1:08 - Take-home thoughts for R/R MM 
3:47 - Summary of BCMA-targeted CAR T-cell therapy; Use of novel agents for R/R MM
6:47 - Information on melphalan flufenamide; Combination approaches with selinexor in clinical practice
9:59 - Cost considerations for treatment options in R/R MM
12:25 - Administration considerations for subcutaneous daratumumab and venetoclax in R/R MM

Faculty

Kathryn Maples, PharmD, BCOP
Clinical Pharmacy Specialist, Multiple Myeloma
Winship Cancer Institute, Emory Healthcare
Atlanta, Georgia

Tim Peterson, PharmD, BCOP
Clinical Pharmacy Specialist – Multiple Myeloma
Memorial Sloan Kettering Cancer Center
New York, New York
 

Content based on a CE activity supported by educational grants from Karyopharm Therapeutics, Inc. and Oncopeptides, Inc.

Link to full activity: 
https://www.proce.com/RRMM

In this episode, Douglas Dieterich, MD, leads a panel discussion with Camilla S. Graham, MD, MPH, and Robert Wong, MD, MS, to consider advantages and barriers to universal screening for chronic HBV infection and universal HDV screening in adults with HBV in the United States. Topics include:

• Updated CDC recommendations for one-time universal screening for HBV
• Addressing patient-, provider-, and system-level barriers to universal HBV screening
• Best practices for implementation of HDV screening

Presenters:

Douglas Dieterich, MD
Director, Institute for Liver Medicine

Professor of Medicine

Division of Liver Diseases

Mount Sinai School of Medicine

New York, New York

Camilla S. Graham, MD, MPH
Co-Director, Viral Hepatitis Clinic
Division of Infectious Diseases
Beth Israel Deaconess Medical Center
Harvard Medical School
Boston, Massachusetts

Robert Wong, MD, MS 
Clinical Associate Professor
Division of Gastroenterology and Hepatology
Stanford University School of Medicine
Palo Alto, California

Link to full program:
https://bit.ly/3TuqFHI

Link to the slides: 
https://bit.ly/4atS42z